We are live on
!
Find out more
Janux Therapeutics
JANX
JANX
176 hedge funds and large institutions have $860M invested in Janux Therapeutics in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 69 increasing their positions, 41 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
68% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 41
16% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 38
1% more funds holding
Funds holding: 174 → 176 (+2)
5.02% less ownership
Funds ownership: 108.44% → 103.42% (-5%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
46% less capital invested
Capital invested by funds: $1.59B → $860M (-$732M)
54% less call options, than puts
Call options by funds: $6.05M | Put options by funds: $13.2M
Holders
176
Holders Change
+2
Holders Change %
+1.15%
% of All Funds
2.14%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
44
Increased
69
Reduced
41
Closed
38
Calls
$6.05M
Puts
$13.2M
Net Calls
-$7.13M
Net Calls Change
-$16.4M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$46.2M |
| 2 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$42.1M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
+$35.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$20.8M |
